Abstract

Atrial fibrillation (AF) is a prevalent cardiac arrhythmia with significant implications for cardiac function and overall health. Despite its historical recognition, its clinical profile and outcomes remain critical for effective management. Methods: This cross-sectional study conducted between March 15, 2022, and December 31, 2022, at the Department of Medicine and Cardiology, Indira Gandhi Medical College and Hospital, Shimla investigated AF's clinical profile and outcomes. Patients with AF were enrolled based on inclusion criteria. Data was collected from 150 hospitalized AF patients aged 18 and above. Demographic data, clinical histories, investigations, treatments, and outcomes were collected and analyzed using Epi Info software. Results: Among 150 participants, the majority were females (71.33%), aged 60-80 years (47.33%), and from varied educational backgrounds. Symptomatic presentation included dyspnea (58.67%), palpitations (34.67%), and chest pain (16%). Comorbidities like hypertension (24.3%), diabetes (18%), and heart failure (8.66%) were observed. Treatment involved beta-blockers (82%), anticoagulants (41.33% Warfarin, 23.33% Rivaroxaban), and diuretics (55.33%). Successful cardioversion was achieved in 81.81% of cases. Conclusion: This study contributes to understanding AF's clinical profile, emphasizing the role of risk factors, comorbidities, and tailored interventions. Early detection, optimized treatment, and multidisciplinary management are crucial to enhance outcomes.

Description